Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.17EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.3.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.95EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
ET.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.34EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EN.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DV.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.11.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-463.749South Korea
GJ.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
HJ.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.101EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.31EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EY.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.35EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EL.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.44EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FU.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.4.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.84EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.1.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.11EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.4.6.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.3EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.40EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DM.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.60EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.49EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CK.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.13EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.9.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XDK.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-1935.15South Korea
XBB.1.16.16EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KT.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
LE.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.7.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
JN.1.49.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.12EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used